Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04829175 · ClinicalTrials.gov registry record

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

A clinical trial of Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Ethicon.

Recruiting
Registry status
1,000
Enrollment target
10
Study locations

NCT04829175 is a study of Pelvic Organ Prolapse and Stress Urinary Incontinence that is actively recruiting participants, run by Ethicon. The registered enrollment target is 1,000 participants, above the 120-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (733% higher). The trial reports 10 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04829175, a study of Pelvic Organ Prolapse and Stress Urinary Incontinence, is actively recruiting participants, sponsored by Ethicon.

RECRUITING
Registry status
1,000 participants
Enrollment target
10
Study locations

Study Summary

The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.

Interventions

  • DEVICE Intervention

Study Locations (10)

Other

  • Krankenhaus der barmherzigen Schwestern - Linz
  • Herlev Hospital - Hillerød
  • Hopital Jeanne de Flandres - Lille
  • Universitatsklinikum Tubingen - Tübingen
  • Bio-Medical University Rome - Rome
  • Karolinska Institute - Stockholm

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • UPMC - Pittsburgh

Connecticut

  • Yale University - New Haven

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-04-11
Est. Completion 2038-03-31

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT04829175

The ClinicalTrials.gov registry entry for NCT04829175 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 120-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (733% higher). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.

NCT04829175 reports 10 study locations spanning 4 distinct geographic areas - top geographies include Other, Pennsylvania, Connecticut.

Frequently Asked Questions

What is clinical trial NCT04829175 about?

NCT04829175 is a clinical study titled "Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry". The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women ...

What is the current status of trial NCT04829175?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-04-11. Estimated completion is 2038-03-31.

What conditions does trial NCT04829175 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse, Stress Urinary Incontinence.

What interventions are being tested in trial NCT04829175?

The interventions under investigation include: Intervention (DEVICE).

Who is sponsoring clinical trial NCT04829175?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04829175 being conducted?

This trial has 10 study locations across Connecticut, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.